RxDoctor Payments Data

Katherina Canales, MD

Geriatric Medicine · Ewing, NJNPI 1740393412

Payments from drug & device makers

$546in general payments, 2019–2025

Across 26 payments — averaging $21.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$138
  • Exact Sciences$62
  • Novo Nordisk$61
  • GSK$45
  • Pfizer$45
  • Edwards Lifesciences$33
  • plus $162 from 8 others

What the payments were for

  • Food & beverage$546100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$546 in reported general payments places this provider in the 55th percentile of 165 geriatric medicine providers in New Jersey.

See all geriatric medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$105,155
Medicare patients
263
Services billed
1,042

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ProliaDenosumab26$46,320
EliquisApixaban23$30,431
TrulicityDulaglutide15$23,683
XareltoRivaroxaban13$20,310
JardianceEmpagliflozin20$19,589
OzempicSemaglutide14$13,612
Fluticasone-SalmeterolFluticasone Propion/Salmeterol49$10,743
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$5,968
Atorvastatin Calcium437$4,129
SynthroidLevothyroxine Sodium46$3,987
Valsartan92$3,648
Venlafaxine Hcl ErVenlafaxine Hcl90$3,491
Levothyroxine Sodium301$3,460
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide56$2,301
Omeprazole157$2,274

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenProlia$15$46,32026 claims
PfizerEliquis$45$30,43123 claims
Lilly USA, LLCTrulicity$14$23,68315 claims
Boehringer IngelheimJardiance$138$19,58920 claims
Novo NordiskOzempic$61$13,61214 claims
GSKAnoro Ellipta$45$5,96813 claims
AbbVieSynthroid$16$3,98746 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 165 geriatric medicine providers in New Jersey.

Other geriatric medicine in Ewing

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →